EYENOVIA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7113 USD | +3.09% |
|
-5.15% | -65.80% |
| 05-15 | Transcript : Eyenovia, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
| 05-15 | Eyenovia, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Greetings and welcome to Eyenovia Corporate Up...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Sector
Pharmaceuticals
Calendar
2024-06-12
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7113
USD
Average target price
9
USD
Spread / Average Target
+1,165.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -65.80% | 38.32M | |
| +38.51% | 727B | |
| +33.05% | 599B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +16.00% | 243B | |
| +8.09% | 205B | |
| -5.77% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- EYEN Stock
- News Eyenovia, Inc.
- Transcript : Eyenovia, Inc. - Special Call
